H-Index
75
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
18%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750

Does recombinant human Tumour Necrosis Factor alpha cause nephrotoxicity?

Małgorzata Muc-Wierzgoń, Katarzyna Madej, Marek Baranowski, D Kaszuba

Med Sci Monit 1996; 2(1): CR28-32

ID: 499516

Published: 1996-01-01


The report presents the results of the treatment of advanced gastrointestinal neoplasms in 17 patients who received intravenous infusions of human recombinant tumour necrosis factor (hr TNF) alpha. A dose escalation scheme was used to establish a maximal, well tolerated dose for each patient. The dose was limited by hr TNF alpha side effects. We noticed a transient non-inflammatory lesion of the renal tubules and glomerules that tended to subside spontaneously after the treatment had been completed. The severity of renal lesion increased with the increase of hr TNF alpha doses and the duration of the therapy. The patients did not require any additional, supportive medication.

Keywords: tumour necrosis factor (TNF), nephrotoxicity, advanced neoplasms



Back